The SEC’s Division of Corporation Finance (CorpFin) recently updated its Compliance & Disclosure Interpretations (C&DIs) titled Non-GAAP Financial Measures, to expand upon situations when non-GAAP financial measures could be considered misleading as well as to clarify its views related to what constitutes undue prominence of non-GAAP measures. In recent public remarks, the SEC staff noted that these updates do not represent a change in their views about non-GAAP financial measures. Rather, the updates stem from CorpFin’s filing review observations and are intended to assist registrants in their disclosure of non-GAAP financial measures.
Misleading
The C&DI updates clarify that presenting a non-GAAP performance measure that excludes normal, recurring, cash operating expenses necessary to operate a registrant’s business is just one example of a measure that could be misleading. Further, when evaluating whether an operating expense is “normal,” the staff considers both the nature and effect of the adjustment and how it relates to the company’s operations, revenue-generating activities, business strategy, industry, and regulatory environment. Further, an operating expense that occurs repeatedly or occasionally, including at irregular intervals, is viewed by the staff as a “recurring” expense [Question 100.01].
The staff also added a nonexhaustive list of examples of (1) individually tailored accounting principles and (2) labeling of the adjustments or non-GAAP measures, which could cause a measure to be misleading [Questions 100.04 and 100.05].
Further, the updates point out that a non-GAAP measure could be misleading even if accompanied by extensive and detailed disclosures about the nature and impact of each adjustment [Question 100.06].
Prominence
The staff provided additional examples where presentation, and any related discussion and analysis, of a non-GAAP measure would be considered more prominent than the most directly comparable GAAP measure [Question 102.10(a)].
The C&DI updates also clarify that the reconciliation needs to start with the most directly comparable GAAP measure. Further, when a registrant presents a forward-looking non-GAAP measure that excludes the quantitative reconciliation under the exception provided in Item 10(e) of Regulation S-K, the staff expects the registrant to disclose with equal or greater prominence the reliance upon the exception as well as the information that is unavailable and its probable significance [Question 102.10(b)].
The C&DI updates also note that when assessing prominence, a non-GAAP income statement is considered to be one that comprises non-GAAP measures and includes all or most of the line items and subtotals found in a GAAP income statement [Question 102.10(c)].
Contacts:
Kendra Decker
National Managing Partner of Professional Practice, Audit Services
Partner, Audit Services, Grant Thornton LLP
Principal, Grant Thornton Advisors LLC
Kendra Decker is the national managing partner of Grant Thornton LLP’s Professional Practice within the firm’s Audit Quality and Risk group.
Arlington, VA
Service Experience
- Audit & Assurance
Rohit Elhance
Partner-in-charge, SEC Regulatory Matters; Audit Quality and Risk
Partner, Audit Services, Grant Thornton LLP
Principal, Grant Thornton Advisors LLC
Rohit Elhance is a partner in SEC Regulatory Matters group, with more than 17 years of international experience serving large multinational and entrepreneurial companies in the areas of audit, risk advisory and transaction services.
Washington DC, Washington DC
Industries
- Construction & real estate
- Manufacturing, Transportation & Distribution
- Technology, media & telecommunications
- Energy
Service Experience
- Advisory
- Audit & Assurance
- Transaction advisory
Cindy Williams
Managing Director, SEC Regulatory Matters
Managing Director, Audit Services
Grant Thornton LLP
Cindy is a managing director in the firm’s SEC Regulatory Matters group, with more than 15 years of auditing, accounting, and SEC reporting experience. She began her career in 2006 in the audit practice where she served public and private companies, primarily in the manufacturing and healthcare industries.
Arlington, Virginia
Industries
- Manufacturing, Transportation & Distribution
- Construction & real estate
- Asset management
Service Experience
- Audit & Assurance
© 2022 Grant Thornton LLP, U.S. member firm of Grant Thornton International Ltd. All rights reserved.
This Grant Thornton LLP bulletin provides information and comments on current accounting issues and developments. It is not a comprehensive analysis of the subject matter covered and is not intended to provide accounting or other advice or guidance with respect to the matters addressed in the bulletin. All relevant facts and circumstances, including the pertinent authoritative literature, need to be considered to arrive at conclusions that comply with matters addressed in this bulletin. For additional information on topics covered in this bulletin, contact your Grant Thornton LLP professional.
More snapshots
No Results Found. Please search again using different keywords and/or filters.